Suppr超能文献

丝氨酸/苏氨酸磷酸酶在破骨细胞生成和骨吸收中的作用。

Serine/threonine phosphatases in osteoclastogenesis and bone resorption.

机构信息

Department of Orthopedic Surgery, University of Minnesota, Minneapolis, MN 55455, United States.

Department of Orthopedic Surgery, University of Minnesota, Minneapolis, MN 55455, United States; Stem Cell Institute, University of Minnesota, Minneapolis, MN 55455, United States.

出版信息

Gene. 2021 Mar 1;771:145362. doi: 10.1016/j.gene.2020.145362. Epub 2020 Dec 16.

Abstract

Maintenance of optimal bone mass is controlled through the concerted functions of several cell types, including bone resorbing osteoclasts. Osteoclasts function to remove calcified tissue during developmental bone modeling, and degrade bone at sites of damage during bone remodeling. Changes to bone homeostasis can arise with alterations in osteoclastogenesis and/or catabolic activity that are not offset by anabolic activity; thus, factors that regulate osteoclastogenesis and bone resorption are of interest to further our understanding of basic bone biology, and as potential targets for therapeutic intervention. Several key cytokines, including RANKL and M-CSF, as well as co-stimulatory factors elicit kinase signaling cascades that promote osteoclastogenesis. These kinase cascades are offset by the action of protein phosphatases, including members of the serine/threonine phosphatase family. Here we review the functions of serine/threonine phosphatases and their control of osteoclast differentiation and function, while highlighting deficiencies in our understanding of this understudied class of proteins within the field.

摘要

维持最佳骨量是通过几种细胞类型的协同作用来控制的,包括破骨细胞。破骨细胞的功能是在发育性骨建模过程中去除钙化组织,并在骨重塑过程中破坏骨部位降解骨。骨稳态的变化可能源于破骨细胞生成和/或分解代谢活性的改变,而这些改变不能被合成代谢活性抵消;因此,调节破骨细胞生成和骨吸收的因素对于进一步了解基本骨生物学以及作为治疗干预的潜在靶点很有意义。几种关键细胞因子,包括 RANKL 和 M-CSF 以及共刺激因子,都会引发激酶信号级联反应,促进破骨细胞生成。这些激酶级联反应被蛋白磷酸酶的作用抵消,包括丝氨酸/苏氨酸磷酸酶家族的成员。在这里,我们综述了丝氨酸/苏氨酸磷酸酶的功能及其对破骨细胞分化和功能的控制,同时强调了我们对该领域中这一研究较少的蛋白质类别的理解存在的不足。

相似文献

9
Mechanisms involved in normal and pathological osteoclastogenesis.正常和病理破骨细胞生成中涉及的机制。
Cell Mol Life Sci. 2018 Jul;75(14):2519-2528. doi: 10.1007/s00018-018-2817-9. Epub 2018 Apr 18.

引用本文的文献

3
Regulation of bone homeostasis: signaling pathways and therapeutic targets.骨稳态的调节:信号通路与治疗靶点
MedComm (2020). 2024 Jul 24;5(8):e657. doi: 10.1002/mco2.657. eCollection 2024 Aug.
7
P2X7Rs: new therapeutic targets for osteoporosis.P2X7Rs:骨质疏松症的新治疗靶点。
Purinergic Signal. 2023 Mar;19(1):207-219. doi: 10.1007/s11302-021-09836-0. Epub 2022 Feb 2.

本文引用的文献

5
Targeting PP2A in cancer: Combination therapies.针对癌症的 PP2A 靶点:联合治疗。
Biochim Biophys Acta Mol Cell Res. 2019 Jan;1866(1):51-63. doi: 10.1016/j.bbamcr.2018.08.020. Epub 2018 Sep 1.
10
Discovery of a periosteal stem cell mediating intramembranous bone formation.发现一种骨膜干细胞介导膜内成骨。
Nature. 2018 Oct;562(7725):133-139. doi: 10.1038/s41586-018-0554-8. Epub 2018 Sep 24.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验